Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 11 de 11
Filter
Add more filters










Publication year range
2.
J Cutan Pathol ; 46(7): 484-489, 2019 Jul.
Article in English | MEDLINE | ID: mdl-30895633

ABSTRACT

BACKGROUND: Muir-Torre syndrome (MTS) is a rare inherited syndrome, with an increased risk of sebaceous and visceral malignancy. Prior reports suggest screening for mismatch repair (MMR) deficiency may be warranted in patients <50 years and when sebaceous neoplasms are located on a non-head and neck location. Previously, appropriate use criteria (AUC) were developed for clinical scenarios in patients >60 years concerning the use of MMR protein immunohistochemistry (MMRP-IHC). This analysis explores the appropriateness of testing in patients ≤60 years. METHODS: Panel raters from the AUC Task Force rated the use of MMRP-IHC testing for MTS for previously rated scenarios with the only difference being age. RESULTS: Results verify the previously developed AUC for the use of MMRP-IHC in neoplasms associated with MTS in patients >60 years. Results also show that in patients ≤60 years with a single sebaceous tumor on a non-head and neck site, MMRP-IHC testing should be considered. Testing can also be considered with a 2-antibody panel on periocular sebaceous carcinoma in younger patients. CONCLUSIONS: Our findings align with known evidence supporting the need to incorporate clinical parameters in identifying patients at risk for MTS, with age being a factor when considering MMRP-IHC testing.


Subject(s)
Aging , Muir-Torre Syndrome , Aged , Aging/metabolism , Aging/pathology , Female , Humans , Immunohistochemistry , Male , Middle Aged , Muir-Torre Syndrome/diagnosis , Muir-Torre Syndrome/metabolism , Muir-Torre Syndrome/pathology
3.
J Am Acad Dermatol ; 80(1): 189-207.e11, 2019 Jan.
Article in English | MEDLINE | ID: mdl-29689323

ABSTRACT

BACKGROUND: Appropriate use criteria (AUC) provide physicians guidance in test selection, and can affect health care delivery, reimbursement policy, and physician decision-making. OBJECTIVES: The American Society of Dermatopathology, with input from the American Academy of Dermatology and the College of American Pathologists, sought to develop AUC in dermatopathology. METHODS: The RAND/UCLA appropriateness methodology, which combines evidence-based medicine, clinical experience, and expert judgment, was used to develop AUC in dermatopathology. RESULTS: With the number of ratings predetermined at 3, AUC were developed for 211 clinical scenarios involving 12 ancillary studies. Consensus was reached for 188 (89%) clinical scenarios, with 93 (44%) considered "usually appropriate" and 52 (25%) "rarely appropriate" and 43 (20%) having "uncertain appropriateness." LIMITATIONS: The methodology requires a focus on appropriateness without comparison between tests and irrespective of cost. CONCLUSIONS: The ultimate decision to order specific tests rests with the physician and is one where the expected benefit exceeds the negative consequences. This publication outlines the recommendations of appropriateness-the AUC for 12 tests used in dermatopathology. Importantly, these recommendations may change considering new evidence. Results deemed "uncertain appropriateness" and where consensus was not reached may benefit from further research.


Subject(s)
Medical Overuse/prevention & control , Skin Diseases/pathology , Dermatology/standards , Humans , Pathology, Clinical/standards
4.
J Cutan Pathol ; 45(8): 563-580, 2018 Aug.
Article in English | MEDLINE | ID: mdl-29566273

ABSTRACT

BACKGROUND: Appropriate use criteria (AUC) provide physicians guidance in test selection, and can affect health care delivery, reimbursement policy and physician decision-making. OBJECTIVES: The American Society of Dermatopathology, with input from the American Academy of Dermatology and the College of American Pathologists, sought to develop AUC in dermatopathology. METHODS: The RAND/UCLA appropriateness methodology, which combines evidence-based medicine, clinical experience and expert judgment, was used to develop AUC in dermatopathology. RESULTS: With the number of ratings predetermined at 3, AUC were developed for 211 clinical scenarios involving 12 ancillary studies. Consensus was reached for 188 (89%) clinical scenarios, with 93 (44%) considered "usually appropriate," 52 (25%) "rarely appropriate" and 43 (20%) "uncertain appropriateness." LIMITATIONS: The methodology requires a focus on appropriateness without comparison between tests and irrespective of cost. CONCLUSIONS: The ultimate decision of when to order specific test rests with the physician and is one where the expected benefit exceeds the negative consequences. This publication outlines the recommendations of appropriateness-AUC for 12 tests used in dermatopathology. Importantly, these recommendations may change considering new evidence. Results deemed "uncertain appropriateness" and where consensus was not reached may benefit from further research.


Subject(s)
Dermatology , Evidence-Based Medicine , Pathology , Diagnostic Tests, Routine , Humans , United States
5.
J Cutan Pathol ; 44(11): 938-943, 2017 Nov.
Article in English | MEDLINE | ID: mdl-28796379

ABSTRACT

Human papillomaviruses have been implicated in many cutaneous diseases. Practicing dermatopathologists often consider using immunohistochemistry and in situ hybridization to help clarify the histologic diagnosis, particularly in cases with borderline or nondiagnostic features. We reviewed the current evidence behind the use of these two techniques in dermatopathology. We identified only two studies utilizing the currently available immunohistochemical antibodies. We found more evidence regarding the use of in situ hybridization; however, the majority of this evidence focuses on diagnosing condylomas and other lesions of the genital skin. We also assessed current utilization patterns of attendees of the American Society of Dermatopathology annual meeting (Chicago, 2016) which revealed a wide spectrum of current utilization ranging from no use to regular use more than once per month. Two-thirds of respondents utilized these tests primarily when requested by the submitting clinician and one-third of the respondents utilize these tests reflexively in specific clinical scenarios.


Subject(s)
Dermatology/methods , Immunohistochemistry/statistics & numerical data , In Situ Hybridization/statistics & numerical data , Papillomavirus Infections/diagnosis , Pathology/methods , DNA, Viral/analysis , Humans , Skin Diseases/diagnosis , Skin Diseases/virology
6.
J Cutan Pathol ; 44(11): 931-937, 2017 Nov.
Article in English | MEDLINE | ID: mdl-28749576

ABSTRACT

Muir-Torre syndrome is a clinical variant of Lynch syndrome defined by the synchronous or metachronous occurrence of at least one sebaceous neoplasm and at least one Lynch syndrome-related internal cancer. Although screening guidelines for patients with colorectal carcinomas have been established, screening guidelines for cutaneous Muir-Torre associated neoplasms are not currently available. As such, we reviewed the current evidence for the use of MLH1, MSH2, MSH6 and PMS2 immunohistochemistry when cutaneous Muir-Torre associated neoplasms are encountered. We identified weak to moderate support overall for the global use of these assays, with some evidence suggesting a tailored approach using clinical parameters as an adjunct. We also assessed the current utilization patterns of attendees of the American Society of Dermatopathology Annual Meeting (Chicago, 2016). We found that 91% of respondents utilize mismatch repair immunohistochemistry, with the majority utilizing these tests only when requested by the submitting clinician.


Subject(s)
Biomarkers, Tumor/analysis , Colorectal Neoplasms/diagnosis , DNA Mismatch Repair , Muir-Torre Syndrome/complications , Sebaceous Gland Neoplasms/diagnosis , Colorectal Neoplasms/etiology , Colorectal Neoplasms/genetics , DNA Repair Enzymes/genetics , Humans , Immunohistochemistry/statistics & numerical data , Muir-Torre Syndrome/genetics , Sebaceous Gland Neoplasms/etiology , Sebaceous Gland Neoplasms/genetics
7.
Am J Dermatopathol ; 37(12): 936-9, 2015 Dec.
Article in English | MEDLINE | ID: mdl-26588339

ABSTRACT

Rosai-Dorfman disease (RDD) is a reactive multisystem histiocytosis that typically presents with cervical lymphadenopathy and systemic symptoms. Cutaneous involvement occurs in approximately 10% of cases, and 3% of cases are limited to the skin without nodal or other extranodal involvement. Langerhans cell histiocytosis (LCH) is a clonal histiocytosis with a wide spectrum of presentations ranging from isolated skin or bone disease to multisystem involvement. Rare case reports have identified concomitant presentation of RDD and LCH; however, most of these reports have involved LCH and RDD occurring concurrently but at separate sites. We present a rare case of concurrent RDD and LCH presenting within a single skin nodule. The patient did not have any evidence of systemic involvement and has remained stable without additional treatment. We also review the literature on this unusual co-presentation and suggest possible underlying mechanisms. Finally, we recommend baseline laboratory and imaging studies and discuss treatment options based on the available evidence.


Subject(s)
Histiocytosis, Langerhans-Cell/complications , Histiocytosis, Sinus/complications , Skin Diseases/complications , Carcinoma, Basal Cell/epidemiology , Comorbidity , Female , Histiocytosis, Langerhans-Cell/pathology , Histiocytosis, Sinus/pathology , Humans , Middle Aged , Skin Diseases/pathology , Skin Neoplasms/epidemiology
8.
J Am Acad Dermatol ; 70(1): 108-14, 2014 Jan.
Article in English | MEDLINE | ID: mdl-24176524

ABSTRACT

BACKGROUND: There are no validated outcome measures for postinflammatory hyperpigmentation (PIH). OBJECTIVE: We sought to determine the reliability and validity of an outcome measure for PIH after acne in patients with skin of color. METHODS: A postacne hyperpigmentation index (PAHPI) was developed. Six raters scored 21 patients with PIH twice. Reliability was determined within and between raters, whereas validity was evaluated by comparing scores with severity ranking by an independent dermatologist. The pigment intensity scores were compared with the melanin index of each patient using a narrowband reflectance spectrophotometer. A quality-of-life score (Skindex-29) was also compared with PAHPI scores. RESULTS: Total PAHPI scores showed good reliability within and between raters and were valid when compared with clinical severity and melanin indices. Good correlation was achieved between the total PAHPI score and the emotion subscale of the Skindex-29. LIMITATIONS: Generalizability of results is limited to African American females. CONCLUSION: The PAHPI shows good reliability and validity when scored on patients with PIH from acne vulgaris. The PAHPI also correlates well with the emotional impact of PIH as measured by the Skindex-29. Future studies should assess the ability of the PAHPI to change with improvement of PIH from acne after treatment.


Subject(s)
Acne Vulgaris/complications , Hyperpigmentation/etiology , Hyperpigmentation/pathology , Severity of Illness Index , Acne Vulgaris/pathology , Adolescent , Adult , Black or African American , Asian People , Dermatitis/pathology , Female , Hispanic or Latino , Humans , Hyperpigmentation/psychology , Male , Melanins/analysis , Observer Variation , Quality of Life , Reproducibility of Results , Spectrophotometry , Young Adult
9.
Am J Dermatopathol ; 34(8): 827-32, 2012 Dec.
Article in English | MEDLINE | ID: mdl-22878366

ABSTRACT

The mitotic rate (MR) of malignant melanoma (MM) refers to the number of mitoses per square millimeter. Studies have suggested that it is an independent prognostic variable predicting survival in patients with MM, and it was recently included in the American Joint Committee on Cancer (AJCC) recommendations for diagnosis and treatment of MM. The AJCC melanoma staging committee recommends using the "hot-spot" approach to determine the MR, whereby it is reported as the maximum dermal mitotic figures identified in a 1-mm area of the melanoma. The AJCC has recommended that the MR be determined in all melanomas, irrespective of Breslow depth or other features. We aimed to quantify the MR in MM ≤1 mm in thickness and to identify statistical associations between the MR, Breslow depth, and Clark level. In addition, we hoped to identify practical issues in determining the MR via the hot-spot technique. We conducted a prospective study to determine the MR, Breslow depth, and Clark level in MM ≤1 mm in thickness. Seven melanomas were identified with epidermal mitoses only (7.4%). Sixteen melanomas had dermal mitoses (16.8%); of these, the majority (75.0%) contained only one mitotic figure. Seventy-nine melanomas had no dermal mitoses (83.2%). Seven lesions (7.4%) demonstrated multiple mitoses; 4 with ≥2 dermal mitoses/mm and 3 with multiple epidermal mitoses. We conclude that thin MM with >1 mitosis/mm is rare and discuss practical and theoretical issues with determining the MR using the hot-spot approach.


Subject(s)
Melanoma/pathology , Mitotic Index , Skin Neoplasms/pathology , Adult , Aged , Aged, 80 and over , Female , Humans , Male , Middle Aged , Mitosis , Prognosis , Young Adult
10.
Vector Borne Zoonotic Dis ; 8(3): 321-9, 2008 Jun.
Article in English | MEDLINE | ID: mdl-18471059

ABSTRACT

UNLABELLED: We conducted serological studies, using epitope-blocking ELISAs directed at West Nile virus (WNV) and flavivirus antibodies, of wild birds in south-central Kansas, the first for this state, in the winters of 2003-04 through 2005-06. Overwintering migratory species (primarily the American tree sparrow and dark-eyed junco) consistently showed significantly lower seropositivity than permanent residents (primarily the northern cardinal). The cardinal showed annual variation in seropositivity between winters. Of 35 birds that were serial sampled within a single winter, one cardinal may have seroconverted between late December and mid-February, providing a preliminary suggestion of continued enzootic transmission, chronic infection, or bird-bird transfer as overwintering mechanisms. Breeding population size of the cardinal did not change after the introduction of WNV to Kansas. Of eighteen birds that were serial sampled between winters, none seroconverted. Among overwintering migrants, the Harris' Sparrow showed the highest seropositivity, possibly related to its migration route through the central Great Plains, an area of recent high WNV activity. The finding that permanent resident birds exhibit higher seropositivity than migrant birds suggests that resident birds contribute to the initiation of annual infection cycles,although this conclusion is speculative in the absence of data on viral titers and the length of viremia. KEYWORDS: West Nile Virus-flavivirus-birds-epitope-blocking ELISA-winter.


Subject(s)
Antibodies, Viral/blood , Bird Diseases/epidemiology , West Nile Fever/veterinary , West Nile virus/immunology , Animal Migration , Animals , Bird Diseases/blood , Bird Diseases/immunology , Birds , Enzyme-Linked Immunosorbent Assay/veterinary , Kansas/epidemiology , Seasons , Time Factors , West Nile Fever/epidemiology , West Nile Fever/immunology
11.
Arch Microbiol ; 185(4): 286-96, 2006 May.
Article in English | MEDLINE | ID: mdl-16518618

ABSTRACT

The current work extends the phenotypic characterization of a bacterial culture collection from the Great Salt Plains of Oklahoma. This barren expanse of mud flats is typically crusted with thalassohaline salt evaporites. The initial account of the aerobic heterotrophic bacteria from the Great Salt Plains described 105 halotolerant isolates that represented 47 phylotypes. Extensive phenotypic analyses were performed on 76 isolates representing 37 unique phylotypes. The current report extends these observations for 60 of the isolates by measuring a wider set of phenotypic characteristics. Utilization patterns for 45 carbon substrates were used to assign the isolates into seven coherent phenons, along with several singletons and a group of isolates that did not grow on single carbon substrates. Most of the isolates were able to utilize nearly all of the nitrogen sources tested, with nitrate being the least utilized. Little antibiotic resistance was seen in the collection as a whole; however, certain phenons were enriched for antibiotic-resistant organisms. A total of 81 phenotypic characteristics were used to generate dendrograms. The numerical taxonomy trees essentially agreed with those generated using 16S rRNA gene sequences. The pattern of carbon substrate utilization showed substantial changes at different salinities that may have relevance to the variable salinities microbes experience at the Salt Plains over time.


Subject(s)
Bacteria, Aerobic/classification , Carbon/metabolism , Drug Resistance, Bacterial , Soil Microbiology , Anti-Bacterial Agents/pharmacology , Bacteria, Aerobic/drug effects , Bacteria, Aerobic/isolation & purification , Bacteria, Aerobic/metabolism , Climate , Ecosystem , Oklahoma , Phenotype , Phylogeny
SELECTION OF CITATIONS
SEARCH DETAIL
...